Treatment options for metastatic hormone-sensitive prostate cancer
Author(s)
Kostos, L; Murphy, DG;
Details
Publication Year 2022-10,Volume 23,Issue #10,Page 1234-1235
Journal Title
Lancet Oncology
Publication Type
Commentary
Keywords
Androgen Antagonists/adverse effects; Hormones; Humans; Male; *Prostatic Neoplasms/drug therapy/pathology
Department(s)
Medical Oncology; Surgical Oncology
PubMed ID
36075259
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-12-20 05:36:47
Last Modified: 2024-12-20 05:37:53

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙